Substance Use Tools & Resources  

Read the Guide

A collection of tools and resources for providers, staff, and patients who offer or use services to address substance use. See the full environmental scan (PDF 0.69 MB) and resources collection (PDF 1.28 MB) in PDF format.

Displaying 11 - 20 of 611

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF

Food and Drug Administration Overdose Prevention Framework

The FDA Overdose Prevention Framework consists of four overarching priorities that align with the U.S. Department of Health & Human Services' Overdose Prevention Strategy to address the public health emergency as it continues to evolve.
Format
Toolkit
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Food and Drug Administration (FDA)
Year
Resource Type
PDF

Healthcare Cost and Utilization Project (HCUP) Fast Stats

HCUP Fast Stats provides easy access to the latest HCUP-based statistics for health care information topics. It uses visual statistical displays in stand-alone graphs, trend figures, or simple tables to convey complex information at a glance. Fast Stats is updated regularly for timely, topic-specific national and State-level statistics.

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
States
Source
Agency for Healthcare Research and Quality
Year
Resource Type
Website

Index to Drug-Specific Information

This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.

Format
Website
Audience
Behavioral Health Providers
Medical Providers
Source
U.S. Food and Drug Administration (FDA)
Year
Resource Type
Website

Integrating SUD and OB/GYN Care: Policy Challenges and Opportunities Final Report

This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Medical Providers
Source
U.S. Department of Health and Human Services (HHS)
Year
Resource Type
PDF

Margolis-FDA Workshop: Identifying Key Competencies for Opioid Prescriber Education

This was a two-day virtual public workshop (which can now be re-watched) that focused on identifying gaps in existing opioid prescriber education offerings and core competencies that should be included in educational content for opioid prescribers and other healthcare providers, including prescriber education under a Risk Evaluation and Mitigation Strategy (REMS).
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video